Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

He, Zhuohao, Guo, Jing L, McBride, Jennifer D, Narasimhan, Sneha, Kim, Hyesung, Changolkar, Lakshmi, Zhang, Bin, Gathagan, Ronald J +9 more·2018·Nature Medicine
DOI 10.1038/nm.4443

Cited by (656)

Items 101–200 of 656

  1. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
    Woo Shik Shin, Jing Di, Qin Cao, Binsen Li, Paul M. Seidler, Kevin A. Murray, Gal Bitan, Lin Jiang · 2019 · Alzheimer s Research & Therapy
  2. Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
    Buccellato, Francesca R., D’Anca, Marianna, Tartaglia, Gianluca Martino, Del Fabbro, Massimo, Scarpini, Elio, Galimberti, Daniela · 2023 · International Journal of Molecular Sciences
  3. Amyloid‐β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease
    Sanchez‐Mico, Maria V., Jimenez, Sebastian, Gomez‐Arboledas, Angela, Muñoz‐Castro, Clara, Romero‐Molina, Carmen, Navarro, Victoria, Sanchez‐Mejias, Elisabeth, Nuñez‐Diaz, Cristina, Sanchez‐Varo, Raquel, Galea, Elena et al. · 2021 · Glia
  4. Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death
    Mengyu Liu, Dexin Sui, Thomas Steven Dexheimer, Stacy Hovde, Xiexiong Deng, Kuang‐Wei Wang, Hsin Lian Lin, Hsiao‐Tien Chien Hagar, Hye Kyong Kweon, Nora Sheen Kuo et al. · 2020 · Molecular Neurobiology
  5. Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
    Gaetano Calabrese, Cristen M. Molzahn, Thibault Mayor · 2022 · Journal of Biological Chemistry
  6. Protein-protein interactions in neurodegenerative diseases: A conspiracy theory
    T. Thompson, P. Chaggar, E. Kuhl, A. Goriely · 2020 · bioRxiv
  7. Age-related diseases as vicious cycles
    Aleksey V. Belikov · 2018 · Ageing Research Reviews
  8. Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
    Wileidy Gómez, Rodrigo Morales, Vinicius Maracaja‐Coutinho, Valentina Parra, Melissa Nassif · 2020 · Aging
  9. Alzheimer’s disease – the journey of a healthy brain into organ failure
    Todd Eliot Golde · 2022 · Molecular Neurodegeneration
  10. Inhibiting Ca2+ channels in Alzheimer’s disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia
    Nils Korte, Anna Barkaway, Jack A. Wells, Felipe Freitas, Huma Sethi, Stephen P. Andrews, John Skidmore, Beth Stevens, David Attwell · 2024 · Nature Neuroscience
  11. A novel electrochemical biosensor with molecularly imprinted polymers and aptamer-based sandwich assay for determining amyloid-β oligomer
    Min You, Shuai Yang, Yu An, Fan Zhang, Pingang He · 2020 · Journal of Electroanalytical Chemistry
  12. Crosstalk of Brain and Bone—Clinical Observations and Their Molecular Bases
    Ellen Otto, P. Knapstein, Denise Jahn, Jessika Appelt, Karl‐Heinz Frosch, Serafeim Tsitsilonis, Johannes Keller · 2020 · International Journal of Molecular Sciences
  13. Aβ plaques
    Lary C. Walker · 2020 · Free Neuropathology
  14. A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease
    Ting Lei, Zhihang Yang, Xue Xia, Yuxiu Chen, Xiaotong Yang, Rou Xie, Fan Tong, Xiaolin Wang, Huile Gao · 2021 · Acta Pharmaceutica Sinica B
  15. Critical Appraisal of Amyloid Lowering Agents in AD
    Boris Decourt, Fadel Boumelhem, Evans D. Pope, Jiong Shi, Zoltan K. Mari, Marwan Noel Sabbagh · 2021 · Current Neurology and Neuroscience Reports
  16. Tau prion-like propagation: state of the art and current challenges
    Dujardin, Simon, Hyman, Bradley T. · 2019 · Advances in Experimental Medicine and Biology
  17. Neuropathological assessment of the Alzheimer spectrum
    K. A. Jellinger · 2020 · Journal of Neural Transmission
  18. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
    Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin · 2023 · Drug Discovery Today
  19. The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders
    Katarzyna Chamera, Ewa Trojan, Magdalena Szuster-Głuszczak, Agnieszka Basta‐Kaim · 2019 · Current Neuropharmacology
  20. TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease
    Seung-Hye Lee, Mitchell G. Rezzonico, Brad A. Friedman, Melanie H. Huntley, William J. Meilandt, Shristi Pandey, Ying-Jiun J. Chen, Amy E. Easton, Zora D. Modrusan, David V. Hansen et al. · 2021 · Cell Reports
  21. Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
    Sun, Zhao, Kwon, Ji-Sun, Ren, Yudong, Chen, Shawei, Walker, Courtney K., Lu, Xinguo, Cates, Kitra, Karahan, Hande, Sviben, Sanja, Fitzpatrick, James A. J. et al. · 2024 · Science
  22. Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD
    John L. Robinson, Ning Yan, Carrie Caswell, Sharon Xiangwen Xie, EunRan R. Suh, Vivianna M. Van Deerlin, Garrett S. Gibbons, David John Irwin, Murray Grossman, Edward B. Lee et al. · 2019 · Journal of Neuropathology & Experimental Neurology
  23. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation
    Luis Aragão Gomes, Valerie Uytterhoeven, Diego Lopez-Sanmartin, Sandra O. Tomé, Thomas Tousseyn, Rik R. Vandenberghe, Mathieu Vandenbulcke, Christine A. F. Von Arnim, Patrik Verstreken, Dietmar Rudolf Thal · 2021 · Acta Neuropathologica
  24. Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation
    Saroja, Sivaprakasam R., Gorbachev, Kirill, Julia, TCW, Goate, Alison M., Pereira, Ana C. · 2022 · Proceedings of the National Academy of Sciences
  25. Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
    Nurul Husna Ibrahim, Mohamad Fairuz Yahaya, Wael M.Y. Mohamed, Seong Lin Teoh, Chua Kien Hui, Jaya Kumar · 2020 · Frontiers in Pharmacology
  26. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia
    Chritica Lodder, Isabelle Scheyltjens, Ilie‐Cosmin Stancu, Pablo Botella Lucena, Manuel Gutiérrez de Ravé, Sarah Vanherle, Tim Vanmierlo, Niels Cremers, Hannah Vanrusselt, Bert Brône et al. · 2021 · Acta Neuropathologica Communications
  27. The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
    Sriram Balusu, Bart De Strooper · 2024 · Acta Neuropathologica
  28. The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
    Ciccone, Lidia, Shi, Chenghui, di Lorenzo, Davide, Van Baelen, Anne-Cécile, Tonali, Nicolo · 2020 · Molecules
  29. Immunotherapy in Parkinson’s disease: Current status and future directions
    Diptaman Chatterjee, Jeffrey H. Kordower · 2019 · Neurobiology of Disease
  30. Neuroprotective Effects of Ginsenoside Rf on Amyloid-β-Induced Neurotoxicity in vitro and in vivo
    Yehong Du, Min Fu, Yu Tian Wang, Zhifang Dong · 2018 · Journal of Alzheimer s Disease
  31. APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading
    Chanung Wang, Aishwarya Nambiar, Michael R. Strickland, Choonghee Lee, Samira Parhizkar, A Moore, Erik S. Musiek, Jason D. Ulrich, David M. Holtzman · 2023 · Journal of Clinical Investigation
  32. The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease
    Charles J. Duyckaerts, Florence Clavaguera, Marie‐Claude Potier · 2019 · Current Opinion in Neurology
  33. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice
    Argyro Thalia Delizannis, Annelies Nonneman, Wangchen Tsering, An De Bondt, Ilse Van den Wyngaert, Bin Zhang, Emily S. Meymand, Modupe F. Olufemi, Pyry P. Koivula, Shaniya Maimaiti et al. · 2021 · Acta Neuropathologica Communications
  34. Ultrasound-Excited Protoporphyrin IX-Modified Multifunctional Nanoparticles as a Strong Inhibitor of Tau Phosphorylation and β-Amyloid Aggregation
    Mengmeng Xu, Hui Zhou, Yanan Liu, Jing Sun, Wenjie Xie, Ping Zhao, Jie Liu · 2018 · ACS Applied Materials & Interfaces
  35. A mechanistic survey of Alzheimer's disease
    Yijing Tang, Dong Zhang, Xiong Gong, Jie Zheng · 2021 · Biophysical Chemistry
  36. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
    Christopher Daniel Morrone, Radha Raghuraman, S. Abid Hussaini, Wai Haung Yu · 2023 · Molecular Neurodegeneration
  37. Distinct brain‐derived TDP‐43 strains from FTLD‐TDP subtypes induce diverse morphological TDP‐43 aggregates and spreading patterns in vitro and in vivo
    Sílvia Porta, Yan Xu, Tagan Lehr, Bin Zhang, Emily S. Meymand, Modupe F. Olufemi, Anna Stieber, Edward B. Lee, John Q. Trojanowski, Virginia M.‐Y. Lee · 2021 · Neuropathology and Applied Neurobiology
  38. Role of SUMOylation in Neurodegenerative Diseases
    Nicolas Mandel, Nitin Agarwal · 2022 · Cells
  39. Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
    Jacob W. Vogel, Yasser Iturria‐Medina, Olof T. Strandberg, Ruben A Smith, Alan Charles Evans, Oskar Hansson, for the Alzheimer’s Disease Neuroimaging Initiative, and the Swedish BioFinder Study · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease
    Tsering, Wangchen, Prokop, Stefan · 2024 · Molecular Neurobiology
  41. Tau Toxicity in Neurodegeneration
    Shuyu Liang, Zuo-Teng Wang, Lan Tan, Jin‐Tai Yu · 2022 · Molecular Neurobiology
  42. The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease
    Heather H. C. Lau, Martin Ingelsson, Joel C. Watts · 2020 · Acta Neuropathologica
  43. Alzheimer disease neuropathology in a patient previously treated with aducanumab
    Edward D. Plowey, Thierry Bussière, Raj Rajagovindan, Jennifer Sebalusky, Stefan Hamann, Christian von Hehn, Carmen Castrillo‐Viguera, Alfred W. Sandrock, Samantha Budd Haeberlein, Christopher H. van Dyck et al. · 2022 · Acta Neuropathologica
  44. Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy
    Tosha Williams, Zachary A. Sorrentino, Mary J. Weinrich, Benoit I. Giasson, Paramita Chakrabarty · 2020 · Brain Communications
  45. Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions
    Mengyu Liu, Thomas Steven Dexheimer, Dexin Sui, Stacy Hovde, Xiexiong Deng, Roland P.S. Kwok, Daniel A. Bochar, Min‐Hao Kuo · 2020 · Scientific Reports
  46. Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review
    Daniela Malafaia, Hélio M. T. Albuquerque, Artur M. S. Silva · 2021 · European Journal of Medicinal Chemistry
  47. Molecular structure of an N-terminal phosphorylated β-amyloid fibril
    Zhiwen Hu, Liliya Vugmeyster, Dan Fai Au, Dmitry Ostrovsky, Yan Ping Sun, Wei Qiang · 2019 · Proceedings of the National Academy of Sciences
  48. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model
    Tomohiro Imamura, Yuki T. Yanagihara, Yasumasa Ohyagi, Norimichi Nakamura, Kyoko Iinuma, Ryo Yamasaki, Hirohide Asai, Masahiro Maeda, Kazuma Murakami, Kazuhiro Irie et al. · 2020 · Neurobiology of Disease
  49. Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease
    Joseph Therriault, Tharick Ali Pascoal, Mélissa Savard, Sulantha Sanjeewa Mathotaarachchi, Andréa Lessa Benedet, Mira Chamoun, Cécile Tissot, Firoza Zubeida Lussier, Nesrine Rahmouni, Jenna Stevenson et al. · 2022 · Science Translational Medicine
  50. A Multifunctional Chemical Agent as an Attenuator of Amyloid Burden and Neuroinflammation in Alzheimer’s Disease
    Hong‐Jun Cho, Anuj K. Sharma, Ying Zhang, Michael L. Gross, Liviu M. Mirica · 2020 · ACS Chemical Neuroscience
  51. Altered ubiquitin signaling induces Alzheimer’s disease-like hallmarks in a three-dimensional human neural cell culture model
    Inbal Maniv, Mahasen Sarji, Anwar Bdarneh, Alona Feldman, Roi Ankawa, Elle Koren, Inbar Magid-Gold, Noa Reis, Despina Soteriou, Shiran Salomon‐Zimri et al. · 2023 · Nature Communications
  52. Involvement of the glymphatic/meningeal lymphatic system in Alzheimer’s disease: insights into proteostasis and future directions
    Kaoru Yamada, Takeshi Iwatsubo · 2024 · Cellular and Molecular Life Sciences
  53. Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer’s Disease
    M. Chami, F. Checler · 2020 · Cells
  54. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders
    Carlson, George A., Prusiner, Stanley B. · 2021 · International Journal of Molecular Sciences
  55. Mesenchymal stromal cells for the treatment of Alzheimer’s disease: Strategies and limitations
    Shobha Regmi, Daniel Dan Liu, Michelle Shen, Bhavesh D. Kevadiya, Abantika Ganguly, Rosita Primavera, Shashank Shankar Chetty, Reza Yarani, Avnesh Sinh Thakor · 2022 · Frontiers in Molecular Neuroscience
  56. Mechanistic new insights of flavonols on neurodegenerative diseases
    Muhammad Shoaib Tahir, Maged Almezgagi, Yu Zhang, Adnan Bashir, Hasnat Mazhar Abdullah, Mohammed Gamah, Xiaozhou Wang, Qinfang Zhu, Xiangqun Shen, Qianqian Ma et al. · 2021 · Biomedicine & Pharmacotherapy
  57. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review
    Hamad Ghaleb Dailah · 2022 · Molecules
  58. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
    Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, Abdel Qader Al Bawab · 2022 · Diagnostics
  59. Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders
    Preetpal Kaur, Alisha Khera, Hema Kumari Alajangi, Akanksha Sharma, Pradeep K. Jaiswal, Gurpal Singh, Ravi Pratap Barnwal · 2022 · Molecular Neurobiology
  60. Catalytic Nanoparticles in Biomedical Applications: Exploiting Advanced Nanozymes for Therapeutics and Diagnostics
    Divinah Manoharan, Liu‐Chun Wang, Ying‐Chi Chen, Weipeng Li, Chen‐Sheng Yeh · 2024 · Advanced Healthcare Materials
  61. Nutrition and Alzheimer Disease
    Shirley Steffany Muñoz Fernández, Sandra María Lima Ribeiro · 2018 · Clinics in Geriatric Medicine
  62. Phosphorylation of the Amyloid-Beta Peptide Inhibits Zinc-Dependent Aggregation, Prevents Na,K-ATPase Inhibition, and Reduces Cerebral Plaque Deposition
    Evgeny P. Barykin, Irina Yu. Petrushanko, Sergey A. Kozin, Georgy B. Telegin, А. С. Чернов, O. D. Lopina, Sergey P. Radko, Vladimir A. Mitkevich, Alexander А. Makarov · 2018 · Frontiers in Molecular Neuroscience
  63. Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
    Lingyan Zheng, Sichen Wu, Haichao Jin, Jiaqi Wu, Xiaole Wang, Yuxiao Cao, Zhihao Zhou, Yaona Jiang, Linhong Li, Xinyue Yang et al. · 2023 · Phytomedicine
  64. In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics
    Hong Wei Xu, Mia O’Reilly, Garrett S. Gibbons, Lakshmi N. Changolkar, Jennifer D. McBride, Dawn M. Riddle, Bin Zhang, Anna Stieber, Jeffrey Nirschl, Soojung Kim et al. · 2021 · Acta Neuropathologica
  65. Two-faced behavior of microglia in Alzheimer’s disease
    Yun Chen, Marco Colonna · 2021 · Nature Neuroscience
  66. Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway
    Yalun Zhang, Yi Zhang, Yahyah Aman, Cheung Toa Ng, Wing Hin Chau, Zhigang Zhang, Ming Yue, Christopher Böhm, Yizhen Jia, Siwen Li et al. · 2021 · Brain
  67. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
    Brendan B. McAllister, Sean G. Lacoursiere, Robert J. Sutherland, Majid H. Mohajerani · 2020 · Neuroscience & Biobehavioral Reviews
  68. Mulberry Fruit Extract Alleviates Cognitive Impairment by Promoting the Clearance of Amyloid-β and Inhibiting Neuroinflammation in Alzheimer’s Disease Mice
    Dianxun Liu, Dongqing Du · 2020 · Neurochemical Research
  69. A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration
    Xiaoyu Yuan, Zhi Jia, Jin Li, Yanan Liu, Yuqin Huang, Youcong Gong, Xian Guo, Xu Chen, Jieqiong Cen, Jie Liu · 2021 · Journal of Materials Chemistry B
  70. Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease
    Sivaprakasam R. Saroja, Abhijeet Sharma, Patrick R. Hof, Ana C. Pereira · 2021 · Alzheimer s & Dementia
  71. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons
    Yiren Qin, Yu Zhang, Inge Tomic, Wenlin Hao, Michael Dieter Menger, Chun‐Feng Liu, Klaus C Fassbender, Yang Liu · 2018 · Journal of Alzheimer s Disease
  72. “Drug‐Carrier” Synergy Therapy for Amyloid‐<i>β</i> Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly
    Han, Guochen, Bai, Kaiwen, Yang, Xiaoyu, Sun, Chenhua, Ji, Yi, Zhou, Jianping, Zhang, Huaqing, Ding, Yang · 2022 · Advanced Science
  73. Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease
    Amanda Li, Joel Tyson, S.G. Patel, Meer Patel, Sruthi Katakam, Xiaobo Mao, Weiwei He · 2021 · Frontiers in Bioengineering and Biotechnology
  74. Reduction of DHHC5-mediated beclin 1 S-palmitoylation underlies autophagy decline in aging
    Rui Guo, Jianping Liu, Xia Min, Wen Zeng, Bing Shan, Mengmeng Zhang, Zhuohao He, Yaoyang Zhang, Kaiwen He, Junying Yuan et al. · 2024 · Nature Structural & Molecular Biology
  75. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
    Cameron Wells, Samuel E. Brennan, Matthew Keon, Nitin Saksena · 2019 · Frontiers in Molecular Neuroscience
  76. Defining and predicting transdiagnostic categories of neurodegenerative disease
    Eli J. Cornblath, John L. Robinson, David John Irwin, Edward B. Lee, Virginia M.‐Y. Lee, John Q. Trojanowski, Danielle S. Bassett · 2020 · Nature Biomedical Engineering
  77. Expanding spectrum of prion diseases
    Jacob I. Ayers, Nick A. Paras, Stanley B. Prusiner · 2020 · Emerging Topics in Life Sciences
  78. Innate Immunity and Cell Death in Alzheimer’s Disease
    SangJoon Lee, Hyunjeong Cho, Jin‐Hyeob Ryu · 2021 · ASN NEURO
  79. Functional Neurophysiological Biomarkers of Early-Stage Alzheimer’s Disease: A Perspective of Network Hyperexcitability in Disease Progression
    Sean Tok, Abdallah Ahnaou, Wilhelmus H. I. M. Drinkenburg · 2021 · Journal of Alzheimer s Disease
  80. Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer’s Disease Neuropathology
    F. Kok, Suzanne van Leerdam, E. D. de Lange · 2022 · Journal of Alzheimer's Disease
  81. Mechanistic complexities of bone loss in Alzheimer’s disease: a review
    Frame, Gabrielle, Bretland, Katie A., Dengler-Crish, Christine M. · 2020 · Connective Tissue Research
  82. Direct Interaction between the β-Amyloid Core and Tau Facilitates Cross-Seeding: A Novel Target for Therapeutic Intervention
    Timir Tripathi, Heena Khan · 2020 · Biochemistry
  83. Neuropathology of the Alzheimer's continuum: an update
    K. A. Jellinger · 2020 · Free Neuropathology
  84. Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease
    Heidi I.L. Jacobs, John Alex Becker, Kenneth K. Kwong, Diana Munera, Liliana A. Ramirez-Gomez, Nina Engels, Justin S. Sanchez, Clara Vila‐Castelar, Ana Y. Baena, Reisa Anne Sperling et al. · 2022 · Alzheimer s & Dementia
  85. Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease
    Finn Peters, Hazal Salihoglu, Katrin Pratsch, Étienne Herzog, Martina Pigoni, Carmelo Sgobio, Stefan F. Lichtenthaler, Ulf Neumann, Jochen Wolfgang Herms · 2019 · The EMBO Journal
  86. Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
    Garrett S. Gibbons, Soojung Kim, Qihui Wu, Dawn M. Riddle, Susan N. Leight, Lakshmi N. Changolkar, Hong Wei Xu, Emily S. Meymand, Mia O’Reilly, Bin Zhang et al. · 2020 · Molecular Neurodegeneration
  87. Metformin beyond an anti-diabetic agent: A comprehensive and mechanistic review on its effects against natural and chemical toxins
    Amirhossein Malaekeh-Nikouei, Sina Shokri-Naei, Sobhan Karbas Foroushan, Hossein Bahari, Vafa Baradaran Rahimi, Reza Heidari, Vahid Reza Askari · 2023 · Biomedicine & Pharmacotherapy
  88. The distinct structural preferences of tau protein repeat domains
    Xuhua Li, Xuewei Dong, Guanghong Wei, Martin Margittai, Ruth Nussinov, Buyong Ma · 2018 · Chemical Communications
  89. Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
    Yixiu Zhou, Yuhui Sun, Quanhong Ma, Yaobo Liu · 2018 · Cell Stress
  90. Diffuse Amyloid- β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons’ Brains Lacking Neuritic Amyloid Plaques
    Erin L. Abner, Janna H. Neltner, Gregory A. Jicha, Ela Patel, Sonya Anderson, Donna M. Wilcock, Linda J. Van Eldik, Peter T. Nelson · 2018 · Journal of Alzheimer s Disease
  91. Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease
    Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence John O'Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh · 2019 · ACS Chemical Neuroscience
  92. Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology
    Marina Friesen, Melanie Meyer‐Luehmann · 2019 · Frontiers in Molecular Neuroscience
  93. Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models
    Veronica Corsetti, Antonella Borreca, Valentina Latina, Giacomo Giacovazzo, Annabella Pignataro, Paraskevi Krashia, Francesca Natale, Sara Cocco, Marco Rinaudo, Francesca Malerba et al. · 2020 · Brain Communications
  94. Abnormal Homocysteine Metabolism: An Insight of Alzheimer’s Disease from DNA Methylation
    Tingting Pi, Bo Liu, Shi Jing-shan · 2020 · Behavioural Neurology
  95. Inflammasomes in neurodegenerative diseases
    Qianchen Wang, Songwei Yang, Xuan Zhang, Shanshan Zhang, Liping Chen, Wanxue Wang, Nai‐Hong Chen, Jiaqing Yan · 2024 · Translational Neurodegeneration
  96. Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
    Christiana Bjorkli, Axel Sandvig, Ioanna Sandvig · 2020 · Frontiers in Aging Neuroscience
  97. APOE Antibody Inhibits Aβ‐Associated Tau Seeding and Spreading in a Mouse Model
    Gratuze, Maud, Jiang, Hong, Wang, Chanung, Xiong, Monica, Bao, Xin, Holtzman, David M. · 2022 · Annals of Neurology
  98. Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer’s disease
    Guo, Qian, Li, Yixian, Xu, Shuting, Wang, Pengzhen, Qian, Kang, Yang, Peng, Sheng, Dongyu, Wang, Liuchang, Cheng, Yunlong, Meng, Ran et al. · 2023 · Journal of Controlled Release
  99. Galectin-3 aggravates microglial activation and tau transmission in tauopathy
    Jian Jing Siew, Hui-Mei Chen, Feng‐Lan Chiu, Chia‐Wei Lee, Yao‐Ming Chang, Hung-Lin Chen, Thi Ngoc Anh Nguyen, Hung-Ting Liao, Mengyu Liu, Hsiao‐Tien Chien Hagar et al. · 2023 · Journal of Clinical Investigation
  100. Tau Protein and Tauopathies: Exploring Tau Protein–Protein and Microtubule Interactions, Cross‐Interactions and Therapeutic Strategies
    Davide Di Lorenzo · 2024 · ChemMedChem